Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication.
Bhargava said, "ICMR sero survey is publication in-progress.
It should appear by this week in the Indian Journal of Medical Research.
It has been peer reviewed.
The second national sero-survey should be completed in the first week September".
On situation of COVID-19 vaccines in India, Balram Bhargava said, "Three COVID-19 vaccines are ahead in the race in India.
Serum Institute's vaccine is in phase 2(B) and phase 3 trials and Bharat Biotech and Zydus Cadila's vaccines have completed phase 1 trial."
